Regulatory Rumblings Archive
June 2019
-
ANA Joins Opposition to HHS Prescription Drug Price Disclosure Rule
Posted: Jun 14, 2019 3:45pm ETANA has joined with Merck, Eli Lilly, and Amgen to bring a lawsuit to enjoin a HHS rule concerning prescription drugs that would otherwise blow significant holes in advertisers First Amendment protections.
READ MORE